Graf Acquisition Corp. IV
Status: Deal Closed
U=S+W/5
W=S@11.50
| IPO Proceeds, $M | $171.62M |
|---|---|
| IPO Date | May 21, 2021 |
| CEO | James A. Graf |
| Left Lead | JP Morgan |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 + 4 |
| IPO Sector |
General
Not specified |
| IPO Geography | Global |
| Target Company | NKGen Biotech |
| Deal Announced | Apr 14, 2023 |
| Deal Size, $M | $184.90M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 25, 2023 |
| Amendment Vote | May 22, 2023 |
| Closing Date | Sep 29, 2023 |
Formerly GFOR
NKGN
NKGNW
| Price | $1.93 |
|---|---|
| Last closing price | $1.71 |
| H/L, today | $1.90 / $1.97 |
| H/L, 52-week | $2.80 / $6.70 |
| Volume, today | 2,056,030 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | $0.14 |
|---|---|
| Last closing price | $0.15 |
| High/low price, today | $0.14 / $0.14 |
| High/low price, 52-week | $0.06 / $0.30 |
| Volume, today | 1,199 |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Graf Acquisition Corp. IV:
- Structure and cap table
- 7 directors & officers
- 45 filings and events
- 2 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| James A. Graf | 56 | CEO |
| Anthony A. Kuznik | 56 | Executive Vice President, General Counsel, Secretary and Director |
| Sabrina McKee | 53 | Executive Vice President, Strategy, and Director |
| Edwin J. Rigaud | 77 | Director |
| A.B. Cruz III | 62 | Director |
| Jeanne L. Manischewitz | 47 | Director |
| Alexandra Lebenthal | 57 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| JP Morgan | Joint BR | 9,750,000 | units |
| Oppenheimer | Joint BR | 5,250,000 | |
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 45 filings.